Ge Li, Ph.D.

Chairman and Chief Executive Officer

One of our founders, entrepreneur; formerly one of the founding scientists of Pharmacopeia. Ph.D. in Organic Chemistry from Columbia University.

Edward Hu

Chief Operating Officer

Formerly Senior Vice President and Chief Operating Officer at Tanox, responsible for operations, finance, IT, project management and strategic planning. MBA and M.S. in Chemistry from Carnegie Mellon University.

Shuhui Chen, Ph.D.

Chief Scientific Officer

Over 18 years' experience in medicinal chemistry, formerly Research Advisor at Eli Lilly, Vion Pharmaceuticals and Bristol-Myers Squibb. Ph.D. in Organic Chemistry from Yale University.

Suhan Tang, Ph.D.

Chief Manufacturing Officer

Over 12 years' experience in development manufacturing industry, formerly a principal scientist at Schering-Plough Research Institute. Ph.D. in Organic Chemistry from Columbia University.

Xiaozhong Liu

Executive Vice President

One of our founders, entrepreneur. B.S. from Peking University and EMBA from China Europe International Business School.

Felix Hsu

Senior Vice President of WuXi AppTec (US)

Over 14 years’ experience at Medtronic, held positions in marketing, quality, operations and general management in MDT Cardiac Surgery and MDT Corporate based in Minneapolis and Hong Kong. MBA from the University of Michigan and B.S. in Electrical Engineering from General Motors Institute.

Richard M. Soll, Ph.D.

Senior Vice President of Integrated Services

Over 25 years' experience in medicinal chemistry, drug discovery and development, formerly Vice President of Research and Development and Chief Scientific Officer at TargeGen. Ph.D. in Chemistry from Dartmouth College and Chemistry post-doctoral fellow at Harvard University.

Trabue D. Bryans

Vice President
General Manager of Atlanta Operations

Over 25 years' experience in medical device industry, Member of the standards board of Association for the Advancement of Medical Instrumentation. B.S. from University of Georgia, M(ASCP) certification in Microbiology from Medical College of Georgia.

Hui Cai, Ph.D.
Vice President of Business Development

Over 11 years’ experience in drug discovery (Johnson & Johnson PRD), strategic planning, business development, and portfolio management; formerly President of Inflexion BioPartners and Vice President of Corporate Development at HUYA Bioscience. B.S. and M.S. in Chemistry from Peking University, Ph.D. from The Scripps Research Institute, and M.B.A. from UCSD Rady School of Management.

Chi-Chung Chan, Ph.D.
Vice President of Pharmacology

Over 26 years' experience of drug discovery in pharmacology, formerly Senior Investigator at Merck Frosst Center for Therapeutic Research, a subsidiary of Merck and Co.  BSc. in Biology from the Chinese University of Hong Kong. Ph.D. in Pharmacology from University of Ottawa. postdoctoral fellowship at the National Research Council of Canada.

Wei-Min Chang
Vice President of Operations General Manager of STA

Over 24 years’ experience in pharmaceutical, biotech and chemical industries. Held VP positions at Eastbound Synopharma (HK) and Taiwan Biotech Co. with various responsibilities including R&D, quality system, regulatory, affairs, API operations, strategic planning and general management. Formerly a senior process engineer at Eli Lilly – Indianapolis. BS in chemistry, MS in chemical engineering and MBA.

Robert Coldreck, RQAP-GLP
Vice President of GLP Quality Assurance

Formerly Director of Laboratory and Preclinical Quality Assurance (QA) North America and Asia for Novartis with over 36 years’ experience in research and Good Laboratory Practice Quality Assurance. B.S. in Biology from Fairleigh Dickinson University.

Dean Enrooth
Vice President of Business
Development – Medical Devices

Over 30 years' experience in strategic acquisition, corporate partnering, product line integration, and new product launch. B.S. in Business with emphasis onon finance from University of Minnesota.

Tao Guo, Ph.D.

Vice President of Medicinal Chemistry

Over 19 years’ experience in organic/medicinal chemistry, formerly Director of Chemistry at Pharmacopeia. B.S. in Chemistry from Peking University, Ph.D. in Organic Chemistry from Columbia University, and postdoctoral fellow in Bioorganic Chemistry at UC Berkeley.

Deepak Hegde, Ph.D.

Vice President of Formulation Development Services

Over 12 years' experience in formulation development and technical transfers in different positions across Rhone Poulenc, Novartis and USV. Ph.D. in Biopharmaceutics and Pharmacokinetics from University of Bombay.

Joseph V. Hughes, Ph.D.

Vice President of Testing Services for Philadelphia Facility

Over 26 years' experience in molecular biology and virology including 8 years' drug and vaccine research development experience at Merck. Ph.D. in Microbiology from Northwestern University.

Scott Kramer

Vice President of Finance and Administration, U.S. Operations

Over 10 years’ experience at Medtronic in senior finance roles supporting operations, R&D, sales, and corporate accounting. Formerly employed with Intel, Western Pioneer and Ernst & Young. MBA in Finance from the Wharton School, University of Pennsylvania, and a licensed CPA.

Qiang Lu, Ph.D.
Vice President of Biology

Over 20 years' experience in biological research and pharmaceutical industry, formerly Principal Scientist/Team Leader at Wyeth and Functional Head at Novartis. Ph.D. in Biochemistry from Brandeis University and postdoctoral fellow at Tufts Medical School in Boston.

Rujian Ma, Ph.D.

Vice President of Synthetic Chemistry

Over 16 years' experience in organic synthesis and in training new fellow scientists. Ph.D. in Pharmaceutical Sciences from the Faculty of Pharmaceutical Sciences, the University of Tokushima.

Naruhito Masai, Ph.D.

Vice President of Business Development for Japan and Specified Region

Formerly General Manager of Global Sales at Sumika Fine Chemicals with over 30 years' industry experience. Ph.D. from Tokyo University.

Lisa Olson

Vice President
General Manager of St. Paul Operations

One of the original laboratory directors at AppTec, U.S. Expert and Co-Chair to ISO Technical Advisory Group on Cytoxicity. B.S. in Microbiology from University of Minnesota.

Donald F. Palme II, Ph.D.

Vice President of Global Toxicology and In Life Services

Over 18 years' experience in pre-clinical research, formerly Executive Corporate Scientist for Heart Failure at Guidant and Acorn Cardiovascular. Ph.D. in Immunology and PathoBiology from University of Minnesota.

Yifeng Shi
Vice President of Operations
Head of Waigaoqiao Site

Over 18 years’ experience in organic synthesis, worked at Shanghai Institute of Organic Chemistry and GLSynthesis. B.S. from Shanghai University of Science and Technology.

Garry Takle, Ph.D.

Vice President of Philadelphia Operations

Over 20 years' experience in biotech/ biopharm industry, worked at Wellcome Biotech (GSK) and Innovir. Ph.D. in Cellular Immunology from the University of Glasgow.

Teri Tanquist

Vice President of Process Improvement and Operations (US)

Over 10 years’ experience in operations, with five years in medical device industry. Held senior positions at Medtronic including the areas of Continuous Improvement, Planning, and Manufacturing. B.S. in Productions and Operations from Winona State University.

Angela Wong, Ph.D.

Vice President of DMPK/ADME

Over 24 years' experience in pharmaceutical research at SmithKline, Pharmacopeia and Vitae Pharmaceuticals. Ph.D. in Pharmacology from Baylor College of Medicine.

Jinsong Xing, Ph.D.
Vice President of Bioanalytical Service

Over 10 years' experience in bioanalytical area, formerly worked at BASF and then Bristol-Myers Squibb. Ph.D. from Rutgers University.

J. Brian Xu, M.D., Ph.D., DABT

Vice President of Toxicology Head of the Safety Evaluation Center

Ph.D. in Pharmacology from The George Washington University, Medical Doctor from Lanzhou Medical College, and American Board-certified toxicologist with over 13 years’ experience in toxicology and drug safety evaluation at Merck, Roche, and Schering-Plough.

Yang-Dar Yuan, D.V.M., Ph.D., Dipl. ACVP, Dipl. ACLAM
Vice President of Operation Head of Pathology of the Safety Evaluation Center

Diplomate of ACVP and ACLAM with 30 years’ experience in preclinical safety assessment and drug development at Upjohn, Pfizer, Allergan and Vitae Pharmaceuticals. D.V.M. from National Taiwan University and Ph.D. in Veterinary Pathology from Cornell University.

Zhaohui Zhang

Vice President of Domestic Marketing

One of our founders, entrepreneur; formerly Vice President of American Silver Bell Company responsible for government procurement. EMBA from China Europe International Business School.

Ning Zhao, Ph.D.

Lead Advisor of Analytical Services Operations

One of our co-founders; formerly Vice President of WuXi's Analytical Department, and held various positions at Bristol-Myers Squibb, Pharmacopeia and Wyeth. Ph.D. in Natural Product and Analytical Chemistry from ColumbiaUniversity.

Hao Zhou

Vice President of Finance

Over 11 years’ experience at General Electric, held positions in financial planning and analysis, accounting, and auditing at GE Healthcare and GE Corporate based in Tokyo, London, and Shanghai. B.A. from Shanghai International Studies University.

Bob Zhu

Vice President of Human Resources and Corporate Communications

Over 18 years' experience in human resources, formerly Head of Asia Human Resources of Electronic Arts and Regional (Asia Pacific) HR Director of Tektronix. B.S. in Law from Fudan University.

Jingchao Dong, Ph.D.
Executive Director, Chemistry

Over 10 years' experience in organic synthesis and medicinal chemistry. Ph.D. in Medicinal Chemistry from Peking University.

Tao Hu, Ph.D.
Executive Director, Chemistry

Over 15 years' experience in organic synthesis and medicinal chemistry, worked at Merck and Amgen. Ph.D. from Boston University and postdoctoral fellow at Harvard University with Professor E. J. Corey.

Yasuhiro Katsu, Ph.D.
 Executive Director, Chemistry

Over 14 years’ experience at Nagoya Laboratories of Pfizer as a medicinal chemist. Ph.D. in Organic Chemistry from Osaka City University.

Jian Li, Ph.D.
Executive Director, Enabling Technologies and Scientific Affairs

Over 20 years’ experience in computational chemistry and computer aided/structure-based drug design. Formerly Senior Scientist at Johnson & Johnson Pharmaceutical R&D. B.S. and Ph.D. from Peking University, postdoctoral fellow from The Scripps Research Institute.

Henry Lu, Ph.D.
Executive Director, Discovery Biology

Over 20 years’ experience in biological research and pharmaceutical industry. Formerly Adjunct Associate Professor at the University of California San Francisco, Senior Director of Infectious Diseases at Rigel Pharmaceuticals Inc. and Principle Scientist at Chiron Corporation (now Novartis). B.S. from Fudan University, Ph.D. from the Shanghai Institute of Biochemistry, Academia Sinica, and postdoctoral fellow at the State University of New York at Stony Brook with Prof. Eckard Wimmer.

Chengde Wu, Ph.D.
Executive Director, Chemistry

Inventor of Thelin® and formerly Director of Medicinal Chemistry at Encysive Pharmaceuticals with 15 years’ experience in US biopharmaceutical drug discovery. Ph.D. in Organic Chemistry from Columbia University with Prof. Gilbert Stork.

Yan Xu, Ph.D.
Executive Director, Chemistry

Over 12 years’ experience in organic synthesis and parallel chemistry. Ph.D. from Nanjing University.

Di Bian, Ph.D.
Senior Director, Pharmacology

Over 20 years’ in vivo pharmacology research and drug discovery experience focusing on analgesic drug discovery and preclinical safety evaluation. Ph.D. in Pharmacology and Toxicology from University of Arizona in Tucson, Arizona.

Peng Cheng, Ph.D.
Senior Director, Chemistry

Over 10 years’ experience in biotechnology/
biopharmaceutical industry, worked at Tularik and Metabolex. Ph.D. in Organic Chemistry from New York University.

Wanyong Feng, Ph.D.
Senior Director, Drug Metabolism, Pharmacokinetics and Bioanalysis

Over 17 years’ experience in bioanalytical chemistry, drug metabolism and pharmacokinetics, formerly Director of Drug Metabolism, Pharmacokinetics and Bioanalytical Chemistry at Bridge Laboratories. Ph.D. in Chemistry from Chinese Academy of Sciences.

Kai Gu, M.S.
Senior Director, Analytical Service

Over 10 years’ experience in analytical and separation. M.S. in Analytical Chemistry from Nanjing University.

Haiying He, Ph.D.
Senior Director, Chemistry

Over 14 years' experience in synthetic and medicinal chemistry, formerly a senior scientist at ImClone System Incorporated. Ph.D. at Huazhong University of Science and Technology and postdoctoral fellow at the SIOC and the University of Florida.

Zhenmin He, Ph.D.
Senior Director, Chemistry

Over 23 years’ experience in organic and medicinal chemistry, formerly a Research
Fellow at Pharmacopeia. Ph.D. from Rutgers University.

Eric Hong, Ph.D.
Senior Director, Chemistry

Worked at Eli Lilly and Rigel Pharmaceuticals for drug discovery with 12 years' experience in pharmaceutical industry. B.S. from Peking University. Ph.D. from University of Wisconsin-Madison.

ChiChang Lee, Ph.D.
Senior Director, Biologics Research

Over 15 years’ experience in biotech/biopharmaceutical
areas, worked at JNJ, MedImmune and GSK. Ph.D. from University of Washington.

Shicheng Liu, Ph.D.
Senior Director, Drug Metabolism and Pharmacokinetics

Over 15 years' experience in DMPK and pharmaceutical industry; formerly worked at Daiichi and then at Nipro. Ph.D. in Pharmaceutical Science from Tokushima University in Japan.

Xiaohang Shen, Ph.D.
Senior Director, Analytical Services

Over 11 years’ experience in GLP bioanalytical analysis, worked at Bristol-Myers Squibb, BASF and Biogen. Ph.D. from Northeastern University.

Hao Wu, Ph.D.
Senior Director, Chemistry

Over 12 years’ experience in organic chemistry and medicinal chemistry. Ph.D. in Medicinal Chemistry from Shanghai Institute of Materia Medica, Chinese Academy of Sciences.

James Wu, Ph.D.
Senior Director, Discovery Biology

Over 9 years' experience in both biotech/pharmaceutical industry and CRO/CMO settings, held positions including senior development scientist in Roche Diagnostics and executive director of protein science at Crown Bioscience Inc. Ph.D. in Cellular and Molecular Biology from University of Michigan and postdoctoral fellow at Eli Lilly.

Dawen Xie, Ph.D.
Senior Director, Biology

Over 18 years' experience in biological research, formerly Research Faculty, and Director of Molecular Epidemiology Core Lab in South Carolina Cancer Center at University of South Carolina. Ph.D. in Molecular Biology from Hamamatsu Medical University in Japan, and postdoctoral fellow at University of Minnesota and Rutgers University in Minneapolis and New Jersey respectively.

Bo Xu, Ph.D.
Senior Director,
Bioprocess Development

Over 10 years of experience in bioprocess development & scale up, formerly principal scientist at CMC Biologics and senior scientist/project leader at AstraZeneca. Ph D in biotechnology from Royal Institute of Technology, Licentiate degree in medicinal chemistry from Karolinska Institute, and B.Sc. in microbiology from Xiamen University.

Hongshi Yu, Ph.D.
Senior Director,
Drug Metabolism and Pharmacokinetics

Over 15 years of industrial experience in drug metabolism, pharmacokinetics and bioanalysis spanning drug discovery and preclinical development. Formerly Section Manager at GlaxoSmithKline. B.S. and M.S. from Peking University, Ph.D. from University of Oklahoma, postdocs at Rutgers and Novartis.

Minzhang Chen, Ph.D.
Executive Director, Process R&D

Over 12 years’ experience in Process R&D and API Manufacturing, formerly Director of Technical Operations at Vertex Pharmaceuticals Inc. Ph.D. in Synthetic Organic Chemistry from University of Minnesota.

Eugene Gong, Ph.D.
Executive Director, Pharmaceutical & Analytical R&D

Formerly Core Team Manager/Associate Principal Scientist in Pharmaceutical R&D of Forest Laboratories, Boehringer Ingelheim Pharmaceuticals and Wyeth Pharmaceuticals with over 12 years’ product development experience. Ph.D. from New York University.

Xiaoguang Wen, Ph.D.
Executive Director of Pharmaceutical Development Services

Worked at Colorcon, Wyeth, Patheon and GSK with over 10 years' experience of formulation development of various dosage forms. Held technical and managerial positions for product development. B.Sc. from Beijing Medical University and Ph.D. in Physical Chemistry from University of Saskatchewan, Canada.

Frank Cai
Senior Director, QC SynTheAll Pharmaceuticals

Over 15 years’ pharmaceutical and biotech industrial experience in analytical research, development and quality control, formerly Staff Analytical Chemist/project leader at Stiefel, a GSK company and senior QC chemist at Oread Manufacturing Contract Service. M.S. in Analytical Chemistry from University of the Pacific, California.

Mei Hao
Senior Director of QA,
SynTheAll Pharmaceuticals

Over 20 years’ GMP experience in chemical and pharmaceutical industries, formerly QA and QC Manager at Novartis China. M.S. in Chemical Engineering from Dalian University of Technology.

Andy Tao, Ph.D.
Senior Director, Process R&D

Over 12 years' experience in pharmaceutical and diagnostic industry, worked at Biosite in San Diego as manager of Reagent Chemistry and at La Jolla Pharmaceutical in
San Diego as research scientist in process development. Ph.D. in Organic Chemistry from University of Illinois.

Youchu Wang, Ph.D.
Senior Director, Process R&D

Over 7 years' experience in process development, formerly a Senior Research Scientist at Chemical Development of Wyeth. Postdoctoral fellow from Memorial University of Newfoundland, Canada and Ph.D. in Organic Chemistry from Chinese Academy of Sciences.

Shaofeng Xie, Ph.D.
Senior Director, Analytical R&D

Over 16 years’ experience in Analytical Science. Formerly HPLC Business Unit Director and Marketing Manager at Teledyne, R&D Director at Dionex, and Analytical R&D Manager at Irvine Pharma. Ph.D. in Chemistry from Cornell University, and MBA from UNL.

Feng Zhang
Senior Director of Production Dept.,
SynTheAll Pharmaceuticals

Over 7 years' experience in process R&D and 4 years' in manufacturing, worked at Zhejiang HISUN Pharmaceutical. B.S. in Pharmacology from Shanghai Medical University.

David Streelman, Ph.D.
Senior Director, Analytical and QC

Over 20 years’ experience in GLP/GMP testing. Previously led central analytical department and toxicology laboratories at Rohm and Haas. Ph.D. in Chemistry from University of Virginia.

Michael S. Burnham, M.S.
Director, Viral Clearance

Over 15 years' experience in the biosafety testing industry, including performance and management of over 300 viral clearance studies, as well as preparation and purification of viral stocks and gene therapy vectors.

Heather D. Malicki, Ph.D.
Director, Virology

Previously worked at Merck for 5 years providing vaccine analytical support to biochemistry and virology quality release laboratories internationally. Ph.D. in Microbiology and Molecular Virology from Thomas Jefferson University.

Yan Zhi, Ph.D.
Associate Director, Molecular Biology

Over 9 years' experience, including project leader at RheoGene, a joint venture between Upstate and Rohm & Haas. Ph.D. in Microbiology and Molecular Genetics from University of California, Irvine.

William C. Bradbury, Ph.D.
Technical Services, Biocompatibility

Over 35 years’ experience providing technical and quality support to medical product industries. Ph.D. in Physical/Organic Chemistry with Biology minor from Cornell University.

Michael Corby
Senior Director, Operations - Atlanta

Worked at DuPont and Merck in Research and Manufacturing. M.S. in Science from Drexel University and MBA from Eastern University.

Barbara Waurzyniak, D.V.M.
Senior Pathologist/Staff Veterinarian

Formerly Director of Pathology Laboratories at Parker Hughes Institute and Paradigm Pharmaceuticals. D.V.M. from Michigan State University and M.S. in Veterinary Anatomic Pathology from Oklahoma State University.

Kristopher Bearson
Director, Biomaterials Manufacturing

Over 15 years’ manufacturing management experience including 8 years in Class III medical device manufacturing. Formerly worked for St. Jude Medical, Gn Resound, Boston Scientific, and Celestica.

Steven J. Elliott
Director, Technical Support
and Custom Studies

Over 15 years’ experience in contract laboratory testing. Serves on AAMI Sterilization Standards committees and with USP Microbiology technical group.

Gordon M. Ely, RM/SM (NRM)
Director, Microbiology Operations

Over 18 years’ experience in medical product laboratory testing. U.S. delegate for ISO/TC working groups and service on working groups for ASQ, AAMI, ASTM and IEST.

Linda K. Hansen, Ph.D.
Director, Custom Studies

Formerly on the faculty of the Department of Laboratory Medicine and Pathology at the University of Minnesota. Ph.D. in Pathobiology from University of Minnesota.

Richard L. Tyson, Ph.D.
Director, Analytical Client
Testing Programs

Over 25 years’ experience, including positions at Becton Dickinson, DuPont, Boehringer Mannheim, DiaSorin, and Remel. Ph.D. in Organic Chemistry from Memphis State University.

Ying Jiang, Ph.D
Executive Director of Laboratory Sciences of Safety Evaluation Center

Over 20 years' biological or pharmaceutical research experience, held positions at Johnson & Johnson, Schering Plough and Merck with responsibilities ranging from early discovery to preclinical safety evaluation. Ph.D. from University of California, Los Angeles, CUSBEA Fellow of 1989, Academic experience including adjunct professorship at Peking University and Kean University.

Anthony L. Kiorpes,
D.V.M., Ph.D., DABT
Executive Director, Toxicology

Diplomate, American Board of Toxicology. Over 20 years' experience including positions at Hazleton/Covance, MGI Pharma and GTC/Primedica/Charles River. D.V.M. from Kansas State and M.S., Ph.D. from University of Wisconsin-Madison.

Yining Qi,
M.D., M.P.H., M.B.A.
Executive Director, Technical Operation, Safety Evaluation Center

Over 20 years' experience in pharmaceutical, medical device industries, CRO and regulatory agency, formerly Research Fellow / Group Leader at Merck. Worked at BD, Johns Hopkins University, SITEK Research Lab and Beijing Institute of Drug Control. M.D. and M.P.H. from Shanxi Medical University and M.B.A. from Rutgers University.

Peter Mu Ph.D.
Senior Director, Toxicology

Over 15 years’ research and industry experience in toxicology. Formerly Associate Director at Lexicon Pharmaceuticals and Study Director at Covance. Ph.D. in Toxicology from North Carolina State University and postdoctoral fellow at CIIT, and MBA from the Johns Hopkins University.

Randy D. White, Ph.D.
Senior Director, Toxicology

Over 20 years' experience, including 14 years' at Baxter Healthcare. Ph.D. in Animal Nutrition/Toxicology from Oregon State University. Member of U.S. ISO Technical Advisory Group (TAG) for Biological Evaluation of Medical Devices.

Hui Xu
Senior Director, Laboratory Operation

Over 10 years’ experience in toxicology and drug safety evaluation in China, worked in JiangSu Center for Safety Evaluation of Drugs. B.S. in Biology from Nankai University.

Xiuying Yang. M.D., Ph.D., Dipl, JSTP, Dipl, JST
Senior Directer, Pathology

Over 12 years' experience in human pathology, and over 12 year's experience in toxicological pathology in pharmaceutical industry and CRO in Japan. M.D. from Shandong Medical University. Ph.D. from Shinshu University School of Medicine in Japan, JSTP-certified Toxicological Pathologist, and JST-certified Toxicologist.

Maureen Speltz, D.V.M.
Veterinary Pathologist

Over 7 years' experience in animal research. Board eligible, American College of Veterinary Pathology. D.V.M. from University of Minnesota.

Robert Sigler,
D.V.M., Ph.D., Dipl. ACVP
Toxicologic Pathologist

Diplomate of and board certified by American College of Veterinary Pathologists. Over 20 years' experience in medical device and pharmaceutical industries and D.V.M. from Michigan State University. Ph.D. from University of Maryland Medical School.

Haiyan Xu, Ph.D.
Senior Director of Toxicology and Senior Study Director

Over 15 years' research and industry experience in toxicology. Formerly Study Director/Scientist at Philip Morris Research Laboratories. Master of Medicine from Zhejiang Medical University and Ph.D. in Medical Sciences from Katholieke University Leuven, Belgium.

Simon Yee, Ph.D.
Director of Toxicology and Senior Study Director

Over 10 years' experience including Study Dir. position in general toxicology at Ricerca and Toxicologist positions at Lorillard and Amgen. Ph.D. in Toxicology from University of California, Irvine.